← Leaderboards
Lu Chen
Schepens Eye Research Institute
$7,427,986
Attributed
$7,427,986
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $855.4K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,427,986 · 3
By mechanism
R01$7,257,606 · 2
F32$170,380 · 1
Top collaborators
No co-investigators on record.
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Ilene K. Gipson$11,024,212
- Nancy C. Joyce$6,341,668
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationLocationLymphoid TissueTissuesFunctional DisorderLymphatic DiseasesLymphedemaIn VivoNovel TherapeuticsRegulationLymphaticGreen Fluorescent ProteinsProtocols DocumentationCellsCell PhysiologyCorneaBaseIn VitroInflammationImmunityGraft SurvivalCategoriesInflammatoryFalls
Grant awards (23)
Novel characterization and therapeutic intervention of Schlemm's canal for glaucoma treatment$380,725
R01 · FY2021 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$392,500
R01 · FY2020 · EY · contact PI
Novel characterization and therapeutic intervention of Schlemm's canal for glaucoma treatment$392,500
R01 · FY2020 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$392,500
R01 · FY2019 · EY · contact PI
Novel characterization and therapeutic intervention of Schlemm's canal for glaucoma treatment$392,500
R01 · FY2019 · EY · contact PI
Novel characterization and therapeutic intervention of Schlemm's canal for glaucoma treatment$392,500
R01 · FY2018 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$392,500
R01 · FY2018 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$392,500
R01 · FY2017 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$383,750
R01 · FY2016 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$376,075
R01 · FY2015 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$376,075
R01 · FY2014 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$364,563
R01 · FY2013 · EY · contact PI
Administrative Supplement to NEI-supported project entitled "Molecular regulation$397,354
R01 · FY2012 · EY · contact PI
Molecular Regulation of Lymphangiogenesis in Corneal Alloimmunity$383,750
R01 · FY2012 · EY · contact PI
Molecular regulation of lymphangiogenesis in corneal alloimmunity$386,387
R01 · FY2010 · EY · contact PI
Molecular regulation of lymphangiogenesis in corneal alloimmunity$423,224
R01 · FY2009 · EY · contact PI
Molecular regulation of lymphangiogenesis in corneal alloimmunity$388,132
R01 · FY2009 · EY · contact PI
Molecular regulation of lymphangiogenesis in corneal alloimmunity$44,028
R01 · FY2009 · EY · contact PI
Molecular regulation of lymphangiogenesis in corneal alloimmunity$300,043
R01 · FY2008 · EY · contact PI
Molecular regulation of lymphangiogenesis in corneal alloimmunity$306,000
R01 · FY2007 · EY · contact PI
Role of Corneal Lymphangiogenesis in Alloimmunity$57,536
F32 · FY2005 · EY
Role of Corneal Lymphangiogenesis in Alloimmunity$56,536
F32 · FY2004 · EY
Role of Corneal Lymphangiogenesis in Alloimmunity$56,308
F32 · FY2003 · EY